Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window (Q37145410)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 2008

edit

Language	Label	Description	Also known as
English	Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window	scientific article published on March 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18430397

retrieved

18 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18430397

retrieved

18 August 2017

main subject

osteoporosis

0 references

author

John P. Bilezikian

series ordinal

1

object named as

John P Bilezikian

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18430397

retrieved

18 August 2017

publication date

1 March 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18430397

retrieved

18 August 2017

published in

Current osteoporosis reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18430397

retrieved

18 August 2017

volume

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18430397

retrieved

18 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18430397

retrieved

18 August 2017

page(s)

24-30

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18430397

retrieved

18 August 2017

cites work

Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months increases cancellous bone formation and improves cancellous architecture: a study of iliac crest biopsies using histomorphometry and micro computed tomography

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteosarcoma and teriparatide?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1-34)]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Intermittent Parathyroid Hormone Administration on Bone Mineralization Density in Iliac Crest Biopsies from Patients with Osteoporosis: A Paired Study before and after Treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daily and cyclic parathyroid hormone in women receiving alendronate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of new vertebral fracture in the year following a fracture

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hormone and periosteal bone expansion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of parathyroid hormone in the treatment of osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: results from the EUROFORS study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of anabolic therapies for osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comments on Initial experience with teriparatide in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New anabolic therapies in osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18430397

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11914-008-0005-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18430397

retrieved

18 August 2017

PubMed publication ID

18430397

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18430397

retrieved

18 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37145410&oldid=2199929236"